FLAD1
Basic information
Region (hg38): 1:154983338-154993111
Links
Phenotypes
GenCC
Source:
- myopathy with abnormal lipid metabolism (Moderate), mode of inheritance: AR
- myopathy with abnormal lipid metabolism (Strong), mode of inheritance: AR
- myopathy with abnormal lipid metabolism (Moderate), mode of inheritance: AR
- myopathy with abnormal lipid metabolism (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Lipid storage myopathy due to FLAD1 deficiency | AR | Biochemical; Cardiovascular | Individuals have shown clinical improvement with dietary management (riboflavin); The condition has been described with cardiomyopathy, and awareness may allow prompt diagnosis and management (eg, with medical management and ICD) | Biochemical; Cardiovascular; Neurologic | 25058219; 27259049 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (8 variants)
- Multiple acyl-CoA dehydrogenase deficiency (8 variants)
- Myopathy with abnormal lipid metabolism (6 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FLAD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 65 | 66 | ||||
missense | 103 | 13 | 121 | |||
nonsense | 5 | |||||
start loss | 2 | |||||
frameshift | 11 | 14 | ||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 2 | 2 | ||||
non coding | 31 | 48 | ||||
Total | 15 | 8 | 118 | 110 | 10 |
Highest pathogenic variant AF is 0.0000197
Variants in FLAD1
This is a list of pathogenic ClinVar variants found in the FLAD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-154983391-C-T | not specified | Likely benign (Aug 02, 2017) | ||
1-154983399-TGA-T | not specified | Likely benign (Feb 01, 2018) | ||
1-154983668-A-G | not specified | Likely benign (Mar 06, 2018) | ||
1-154983727-G-C | Uncertain significance (Jul 17, 2022) | |||
1-154983729-G-A | Uncertain significance (Jan 12, 2024) | |||
1-154983730-G-A | Likely benign (Oct 30, 2023) | |||
1-154983747-G-A | Inborn genetic diseases | Uncertain significance (Jun 07, 2023) | ||
1-154983767-G-C | Uncertain significance (Dec 26, 2021) | |||
1-154983772-G-A | Likely benign (Oct 05, 2023) | |||
1-154983779-G-T | Inborn genetic diseases | Uncertain significance (Nov 11, 2024) | ||
1-154983791-G-A | Uncertain significance (Oct 17, 2022) | |||
1-154983806-C-G | Uncertain significance (Jun 11, 2022) | |||
1-154983814-C-G | Likely benign (Aug 09, 2022) | |||
1-154983816-C-T | Uncertain significance (Mar 18, 2022) | |||
1-154983822-G-A | Inborn genetic diseases | Uncertain significance (May 23, 2023) | ||
1-154983824-C-T | Uncertain significance (Nov 18, 2022) | |||
1-154983830-T-C | Uncertain significance (Apr 27, 2021) | |||
1-154983851-A-T | Uncertain significance (May 30, 2022) | |||
1-154983883-C-G | Likely benign (Jun 06, 2023) | |||
1-154983892-T-C | Likely benign (Nov 24, 2023) | |||
1-154983897-A-G | Uncertain significance (Nov 25, 2024) | |||
1-154983901-G-C | Likely benign (Sep 24, 2022) | |||
1-154983903-C-CA | Uncertain significance (Jan 05, 2022) | |||
1-154983910-C-T | Likely benign (Jul 06, 2022) | |||
1-154983926-C-T | Likely benign (Nov 10, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FLAD1 | protein_coding | protein_coding | ENST00000292180 | 7 | 9774 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00936 | 0.990 | 125706 | 0 | 42 | 125748 | 0.000167 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.581 | 306 | 336 | 0.911 | 0.0000190 | 3728 |
Missense in Polyphen | 92 | 103.66 | 0.88755 | 1144 | ||
Synonymous | 1.72 | 111 | 137 | 0.812 | 0.00000702 | 1273 |
Loss of Function | 3.07 | 8 | 24.4 | 0.328 | 0.00000131 | 271 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000416 | 0.000416 |
Ashkenazi Jewish | 0.000202 | 0.000198 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000194 | 0.000193 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the adenylation of flavin mononucleotide (FMN) to form flavin adenine dinucleotide (FAD) coenzyme. {ECO:0000269|PubMed:16643857, ECO:0000269|PubMed:27259049}.;
- Disease
- DISEASE: Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency (LSMFLAD) [MIM:255100]: An autosomal recessive, inborn error of metabolism characterized by variable mitochondrial dysfunction. Clinical features range from severe cardiac and respiratory insufficiency with onset in infancy and resulting in early death, to mild muscle weakness with onset in adulthood. Some patients show significant improvement with riboflavin treatment. Analysis of skeletal muscle show multiple mitochondrial respiratory chain deficiency and a lipid storage myopathy in most patients. {ECO:0000269|PubMed:27259049}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Riboflavin metabolism - Homo sapiens (human);Riboflavin Metabolism;Selenium Micronutrient Network;Folate Metabolism;Metabolism;Vitamin B2 (riboflavin) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;flavin biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.232
Intolerance Scores
- loftool
- 0.0672
- rvis_EVS
- -1.04
- rvis_percentile_EVS
- 7.71
Haploinsufficiency Scores
- pHI
- 0.114
- hipred
- N
- hipred_score
- 0.371
- ghis
- 0.639
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.999
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Flad1
- Phenotype
Gene ontology
- Biological process
- FAD biosynthetic process;riboflavin metabolic process
- Cellular component
- mitochondrial matrix;cytosol;plasma membrane
- Molecular function
- FMN adenylyltransferase activity;protein binding;ATP binding